PlainRecalls
FDA Drug Moderate Class II Terminated

Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.

Reported: March 25, 2020 Initiated: March 13, 2020 #D-1032-2020

Product Description

Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.

Reason for Recall

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Details

Units Affected
624 bottles
Distribution
Nationwide in the USA
Location
Cranbury, NJ

Frequently Asked Questions

What product was recalled?
Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.. Recalled by Sun Pharmaceutical Industries, Inc.. Units affected: 624 bottles.
Why was this product recalled?
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 25, 2020. Severity: Moderate. Recall number: D-1032-2020.